Cancer Communications,
Journal Year:
2022,
Volume and Issue:
42(12), P. 1234 - 1256
Published: Sept. 15, 2022
Abstract
Pancreatic
cancer
is
one
of
the
most
serious
health
issues
in
developed
and
developing
countries,
with
a
5‐year
overall
survival
rate
currently
<9%.
Patients
typically
present
advanced
disease
due
to
vague
symptoms
or
lack
screening
for
early
detection.
Surgical
resection
represents
only
chance
cure,
but
treatment
options
are
limited
diseases,
such
as
distant
metastatic
locally
progressive
tumors.
Although
adjuvant
chemotherapy
has
improved
long‐term
outcomes
patients,
its
response
low.
So,
exploring
other
new
treatments
urgent.
In
recent
years,
increasing
evidence
shown
that
lipid
metabolism
can
support
tumorigenesis
progression
well
resistance
through
enhanced
synthesis,
storage,
catabolism.
Therefore,
better
understanding
networks
may
provide
novel
promising
strategies
diagnosis,
prognosis
estimation,
targeted
therapy
pancreatic
patients.
this
review,
we
first
enumerate
discuss
current
knowledge
about
advances
made
regulation
cancer.
addition,
summarize
preclinical
studies
clinical
trials
drugs
targeting
metabolic
systems
Finally,
highlight
challenges
opportunities
pathways
precision
therapies
The Journal of Experimental Medicine,
Journal Year:
2022,
Volume and Issue:
219(6)
Published: April 19, 2022
CD36
is
a
type
2
cell
surface
scavenger
receptor
widely
expressed
in
many
immune
and
non-immune
cells.
It
functions
as
both
signaling
responding
to
DAMPs
PAMPs,
well
long
chain
free
fatty
acid
transporter.
Recent
studies
have
indicated
that
can
integrate
metabolic
pathways
through
its
dual
thereby
influence
differentiation
activation,
ultimately
help
determine
fate.
Its
expression
along
with
innate
adaptive
cells
contribute
pathogenesis
of
common
diseases,
including
atherosclerosis
tumor
progression,
which
makes
downstream
effectors
potential
therapeutic
targets.
This
review
comprehensively
examines
the
variety
cells,
especially
macrophages
T
We
also
briefly
discuss
function
such
adipocytes
platelets,
impact
system
via
intercellular
communication.
Finally,
outstanding
questions
this
field
are
provided
for
directions
future
studies.
Frontiers in Oncology,
Journal Year:
2021,
Volume and Issue:
10
Published: Feb. 2, 2021
Obesity
and
type
2
diabetes
have
both
been
associated
with
increased
cancer
risk
are
becoming
increasingly
prevalent.
Metabolic
abnormalities
such
as
insulin
resistance
dyslipidemia
obesity
implicated
in
the
obesity-cancer
relationship.
Multiple
mechanisms
proposed
to
link
progression,
including
an
increase
insulin/IGF-1
signaling,
lipid
glucose
uptake
metabolism,
alterations
profile
of
cytokines,
chemokines,
adipokines,
well
changes
adipose
tissue
directly
adjacent
sites.
This
review
aims
summarize
provide
update
on
epidemiological
mechanistic
evidence
linking
cancer,
focusing
roles
insulin,
lipids,
tissue.
Journal of Hematology & Oncology,
Journal Year:
2021,
Volume and Issue:
14(1)
Published: Nov. 6, 2021
Complex
interactions
between
the
immune
system
and
tumor
cells
exist
throughout
initiation
development
of
cancer.
Although
eliminates
malignantly
transformed
in
early
stage,
surviving
evade
host
defense
through
various
methods
even
reprogram
anti-tumor
response
to
a
pro-tumor
phenotype
obtain
unlimited
growth
metastasis.
The
high
proliferation
rate
increases
demand
for
local
nutrients
oxygen.
Poorly
organized
vessels
can
barely
satisfy
this
requirement,
which
results
an
acidic,
hypoxic,
glucose-deficient
microenvironment.
As
result,
lipids
microenvironment
are
activated
utilized
as
primary
source
energy
critical
regulators
both
related
cells.
However,
exact
role
lipid
metabolism
reprogramming
remains
unclear.
A
comprehensive
understanding
dysfunction
its
dual
effects
on
is
mapping
detailed
landscape
immunology
developing
specific
treatments
cancer
patients.
In
review,
we
have
focused
dysregulation
discussed
contradictory
roles
response.
addition,
summarized
current
therapeutic
strategies
targeting
immunotherapy.
This
review
provides
summary
Molecular Cancer,
Journal Year:
2023,
Volume and Issue:
22(1)
Published: Oct. 2, 2023
Abstract
Despite
centuries
since
the
discovery
and
study
of
cancer,
cancer
is
still
a
lethal
intractable
health
issue
worldwide.
Cancer-associated
fibroblasts
(CAFs)
have
gained
much
attention
as
pivotal
component
tumor
microenvironment.
The
versatility
sophisticated
mechanisms
CAFs
in
facilitating
progression
been
elucidated
extensively,
including
promoting
angiogenesis
metastasis,
inducing
drug
resistance,
reshaping
extracellular
matrix,
developing
an
immunosuppressive
Owing
to
their
robust
tumor-promoting
function,
are
considered
promising
target
for
oncotherapy.
However,
highly
heterogeneous
group
cells.
Some
subpopulations
exert
inhibitory
role
growth,
which
implies
that
CAF-targeting
approaches
must
be
more
precise
individualized.
This
review
comprehensively
summarize
origin,
phenotypical,
functional
heterogeneity
CAFs.
More
importantly,
we
underscore
advances
strategies
clinical
trials
CAF
various
cancers,
also
progressions
immunotherapy.
Journal of Hematology & Oncology,
Journal Year:
2023,
Volume and Issue:
16(1)
Published: Sept. 12, 2023
Abstract
Lipid
metabolic
reprogramming
is
an
emerging
hallmark
of
cancer.
In
order
to
sustain
uncontrolled
proliferation
and
survive
in
unfavorable
environments
that
lack
oxygen
nutrients,
tumor
cells
undergo
transformations
exploit
various
ways
acquiring
lipid
increasing
oxidation.
addition,
stromal
immune
the
microenvironment
also
reprogramming,
which
further
affects
functional
phenotypes
responses.
Given
metabolism
plays
a
critical
role
supporting
cancer
progression
remodeling
microenvironment,
targeting
pathway
could
provide
novel
approach
treatment.
This
review
seeks
to:
(1)
clarify
overall
landscape
mechanisms
cancer,
(2)
summarize
landscapes
within
their
roles
progression,
(3)
potential
therapeutic
targets
for
metabolism,
highlight
combining
such
approaches
with
other
anti-tumor
therapies
new
opportunities
patients.
Oncogenesis,
Journal Year:
2022,
Volume and Issue:
11(1)
Published: Aug. 9, 2022
Abstract
Lipids
are
essential
constituents
for
malignant
tumors,
as
they
absolutely
required
tumor
growth
and
dissemination.
Provided
by
the
microenvironment
(TME)
or
cancer
cells
themselves
through
activation
of
de
novo
synthesis
pathways,
orchestrate
a
large
variety
pro-tumorigenic
functions.
Importantly,
TME
cells,
especially
immune
cancer-associated
fibroblasts
(CAFs)
adipocytes
(CAAs),
also
prone
to
changes
in
their
lipid
content,
which
hinder
promote
aggressiveness.
In
this
review,
we
address
significant
findings
contribution
progression
towards
metastatic
disease
poor
response
therapeutic
treatments.
We
highlight
benefits
targeting
pathways
preclinical
models
slow
down
metastasis
development
overcome
chemo-and
immunotherapy
resistance.
OncoImmunology,
Journal Year:
2022,
Volume and Issue:
11(1)
Published: June 8, 2022
The
tumor-adipose
microenvironment
(TAME)
is
a
universal
microecosystem,
that
characterized
by
the
dysfunction
of
lipid
metabolism,
such
as
excessive
free
fatty
acids
(FFAs).
Macrophages
are
most
abundant
immune
cell
type
within
TAME,
although
their
diversity
in
TAME
not
clear.
We
first
reveal
infiltration
M2-like
macrophages
associated
with
poor
survival
breast
cancer.
To
explore
lipid-associated
alterations
we
also
detected
levels
FFAs
transporters
including
acid
binding
proteins
(FABPs)
and
transport
protein
1
(FATP1).
results
indicated
expression
tightly
linked
to
function
predicts
impact
on
macrophages,
performed
single-cell
RNA
sequencing
(scRNA-seq)
spatial
transcriptomics.
Consequently,
identified
special
subpopulation
defined
(LAMs),
highly
expressed
macrophage
markers
(CD163,
SPP1
C1QC),
genes
involved
metabolism
(FABP3,
FABP4,
FABP5,
LPL
LIPA)
some
receptors
(LGALS3
TREM2).
Functionally,
LAMs
were
canonical
functional
signature
accumulation
enhancing
phagocytosis,
they
mostly
distributed
junctional
regions.
Finally,
allograft
cancer
mouse
models
confirmed
depletion
synergizes
antitumorigenic
effects
anti-PD1
therapy.
In
summary,
novel
subtype
has
unique
features
clinical
outcomes.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: July 5, 2024
Abstract
Cancer
stem
cells
(CSCs),
a
small
subset
of
in
tumors
that
are
characterized
by
self-renewal
and
continuous
proliferation,
lead
to
tumorigenesis,
metastasis,
maintain
tumor
heterogeneity.
continues
be
significant
global
disease
burden.
In
the
past,
surgery,
radiotherapy,
chemotherapy
were
main
cancer
treatments.
The
technology
treatments
develop
advance,
emergence
targeted
therapy,
immunotherapy
provides
more
options
for
patients
certain
extent.
However,
limitations
efficacy
treatment
resistance
still
inevitable.
Our
review
begins
with
brief
introduction
historical
discoveries,
original
hypotheses,
pathways
regulate
CSCs,
such
as
WNT/β-Catenin,
hedgehog,
Notch,
NF-κB,
JAK/STAT,
TGF-β,
PI3K/AKT,
PPAR
pathway,
their
crosstalk.
We
focus
on
role
CSCs
various
therapeutic
outcomes
resistance,
including
how
affect
content
alteration
related
molecules,
CSCs-mediated
clinical
value
targeting
refractory,
progressed
or
advanced
tumors.
summary,
efficacy,
method
is
difficult
determine.
Clarifying
regulatory
mechanisms
biomarkers
currently
mainstream
idea.
Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
13
Published: March 31, 2022
Fatty
acid
metabolism
has
been
deciphered
to
augment
tumorigenesis
and
disease
progression
in
addition
therapy
resistance
via
strengthened
lipid
synthesis,
storage,
catabolism.
Breast
cancer
is
strongly
associated
with
the
biological
function
of
fatty
owing
abundant
presence
adipocytes
breast
tissue.
It
unraveled
that
tumor
cells
exhibit
considerable
plasticity
based
on
metabolism,
responding
extra-tumoral
a
range
metabolic
signals,
which
microenvironment
plays
pivotal
role.
However,
prognostic
significance
remains
be
further
investigated.
Alongside
these
insights,
we
retrieved
269
reliable
metabolism-related
genes
(FMGs)
identified
landscape
copy
number
variations
expression
level
among
those
genes.
Additionally,
11
overall
survival-related
FMGs
were
clarified
by
univariate
Cox
hazards
regression
analysis
The
Cancer
Genome
Atlas
(TCGA)
Molecular
Taxonomy
International
Consortium
(METABRIC)
databases.
Subsequently,
signature
6
survival
(OS)-related
was
generated
using
Lasso
TCGA
dataset
validated
two
external
cohorts.
correlation
between
several
essential
clinical
parameters,
including
T,
N,
PAM50
subtypes,
unveiled
comparing
accumulating
value
various
degrees.
Furthermore,
an
optimal
nomogram
incorporating
signature,
age,
American
Joint
Committee
(AJCC)
stage
constructed,
discrimination
verified
C-index,
calibration
curve,
decision
curve
analysis.
underlying
implications
for
immune
checkpoints
inhibitors,
microenvironment,
predictive
diverse
strategies
depicted
ultimately.
In
conclusion,
our
findings
indicate
potential
connotation
cancer,
supporting
novel
insights
into
patients'
prognosis
administrating
effective
immunotherapy.